ORIG3N is a biotechnology company, collects DNA samples and researches and develops treatments for genetically inherited diseases.

Orig3n helps people understand the links between their genes and how their minds and bodies work. The company operates an online application for selling DNA test kits, collecting genetic samples for the research and development, and provides DNA results.

ORIG3N was founded in 2014 and is based in Boston, Massachusetts.

Orig3n develops an induced pluripotent stem cell technology that can be differentiated to become any cell type in the body; and can be used to test drugs for efficacy, screen medications for toxicity, and determine a path towards a personalized approach to treatment.

ORIG3N product portfolio includes LifeProfiles, a series of genetic tests comprising FITCODE that provides reports and insights on various aspects of fitness, including metabolism, muscle strength, endurance, joints, power performance, and exercise recovery; and AURA for assessment and insight on various aspects of skin, as well as Life Capsule, a blood cell repository for regenerative medicine development.  


ORIG3N's investors include Haitong International Securities Group Vectr Ventures, Spectrum Health Ventures etc. The company has acquired Interleukin Genetics in Nov 22, 2017 to date.



  • Year founded: 2014
  • Funding Info: $50M in 4 funding Rounds (Last funding type: Venture - Series B)- It has also acquired Interleukin Genetics in Nov 22, 2017 to date.
  • Yearly Revenue: $5M-$10M (2018)
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Boston
  • State: Massachusetts
  • Country: United States
Related businesses